ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 27 filers reported holding ADMA BIOLOGICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $446,000,000 | +57.6% | 75,000 | +114.3% | 0.01% | +100.0% |
Q1 2016 | $283,000,000 | -4.1% | 35,000 | -3.8% | 0.01% | 0.0% |
Q4 2015 | $295,000,000 | -3.0% | 36,400 | 0.0% | 0.01% | -16.7% |
Q3 2015 | $304,000,000 | -9.8% | 36,400 | 0.0% | 0.01% | 0.0% |
Q2 2015 | $337,000,000 | -16.2% | 36,400 | -11.2% | 0.01% | -33.3% |
Q1 2015 | $402,000,000 | – | 41,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Velan Capital Investment Management LP | 5,269,155 | $12,804,000 | 12.70% |
Stonepine Capital Management, LLC | 5,000,000 | $12,150,000 | 5.46% |
Altium Capital Management LP | 2,883,710 | $7,007,000 | 2.57% |
AWM Investment Company, Inc. | 5,015,000 | $12,186,000 | 1.85% |
Potomac Capital Management, Inc. | 482,000 | $1,171,000 | 1.34% |
Perceptive Advisors | 10,933,387 | $26,568,000 | 0.77% |
EAM Investors, LLC | 1,427,160 | $3,468,000 | 0.75% |
Clearline Capital LP | 2,496,297 | $6,066,000 | 0.72% |
EAM Global Investors LLC | 836,323 | $2,032,000 | 0.54% |
BOOTHBAY FUND MANAGEMENT, LLC | 8,121,153 | $19,734,000 | 0.49% |